217 related articles for article (PubMed ID: 35805924)
21. Elevated stress hormone levels and antidepressant treatment starting before pregnancy affect maternal care and litter characteristics in an animal model of depression.
Kott JM; Mooney-Leber SM; Li J; Brummelte S
Behav Brain Res; 2018 Aug; 348():101-114. PubMed ID: 29630906
[TBL] [Abstract][Full Text] [Related]
22. Association of Antidepressant Medications With Incident Type 2 Diabetes Among Medicaid-Insured Youths.
Burcu M; Zito JM; Safer DJ; Magder LS; dosReis S; Shaya FT; Rosenthal GL
JAMA Pediatr; 2017 Dec; 171(12):1200-1207. PubMed ID: 29049533
[TBL] [Abstract][Full Text] [Related]
23. Fluoxetine attenuates stress-induced depressive-like behavior through modulation of hippocampal GAP43 and neurogenesis in male rats.
Zavvari F; Nahavandi A; Goudarzi M
J Chem Neuroanat; 2020 Jan; 103():101711. PubMed ID: 31705954
[TBL] [Abstract][Full Text] [Related]
24. [Antidepressant and tolerance: Determinants and management of major side effects].
David DJ; Gourion D
Encephale; 2016 Dec; 42(6):553-561. PubMed ID: 27423475
[TBL] [Abstract][Full Text] [Related]
25. Temporal trends of antidepressant utilization patterns in children and adolescents in Hong Kong: A 14-year population-based study with joinpoint regression analysis.
Lo HKY; Tong CCHY; Chan JKN; Kam CTK; Wong CSM; Cheng CPW; Ho C; Leung BMH; Wong WSH; Yu ZHS; Chang WC
J Affect Disord; 2024 Jan; 344():61-68. PubMed ID: 37827253
[TBL] [Abstract][Full Text] [Related]
26. Edivoxetine compared to placebo as adjunctive therapy to selective serotonin reuptake inhibitors in the prevention of symptom re-emergence in major depressive disorder.
Oakes TM; Dellva MA; Waterman K; Greenbaum M; Poppe C; Goldberger C; Ahl J; Perahia DG
Curr Med Res Opin; 2015 Jun; 31(6):1179-89. PubMed ID: 25894953
[TBL] [Abstract][Full Text] [Related]
27. Fluoxetine effects on behavior and adult hippocampal neurogenesis in female C57BL/6J mice across the estrous cycle.
Yohn CN; Shifman S; Garino A; Diethorn E; Bokka L; Ashamalla SA; Samuels BA
Psychopharmacology (Berl); 2020 May; 237(5):1281-1290. PubMed ID: 31965254
[TBL] [Abstract][Full Text] [Related]
28. Maternal fluoxetine reduces hippocampal inflammation and neurogenesis in adult offspring with sex-specific effects of periadolescent oxytocin.
Qiu W; Go KA; Wen Y; Duarte-Guterman P; Eid RS; Galea LAM
Brain Behav Immun; 2021 Oct; 97():394-409. PubMed ID: 34174336
[TBL] [Abstract][Full Text] [Related]
29. Future directions for serotonin and antidepressants.
Artigas F
ACS Chem Neurosci; 2013 Jan; 4(1):5-8. PubMed ID: 23336036
[TBL] [Abstract][Full Text] [Related]
30. Comparison of adjunctive use of aripiprazole with bupropion or selective serotonin reuptake inhibitors/serotonin-norepinephrine reuptake inhibitors: analysis of patients beginning adjunctive treatment in a 52-week, open-label study.
Clayton AH; Baker RA; Sheehan JJ; Cain ZJ; Forbes RA; Marler SV; Marcus R; Berman RM; Thase ME
BMC Res Notes; 2014 Jul; 7():459. PubMed ID: 25037144
[TBL] [Abstract][Full Text] [Related]
31. Pharmacological and behavioral characterization of D-473, an orally active triple reuptake inhibitor targeting dopamine, serotonin and norepinephrine transporters.
Dutta AK; Santra S; Sharma H; Voshavar C; Xu L; Mabrouk O; Antonio T; Reith ME
PLoS One; 2014; 9(11):e113420. PubMed ID: 25427177
[TBL] [Abstract][Full Text] [Related]
32. Selective serotonin reuptake inhibitors versus tricyclic antidepressants in young patients: a meta-analysis of efficacy and acceptability.
Qin B; Zhang Y; Zhou X; Cheng P; Liu Y; Chen J; Fu Y; Luo Q; Xie P
Clin Ther; 2014 Jul; 36(7):1087-1095.e4. PubMed ID: 24998011
[TBL] [Abstract][Full Text] [Related]
33. Genetic dysfunction of serotonin 2A receptor hampers response to antidepressant drugs: A translational approach.
Qesseveur G; Petit AC; Nguyen HT; Dahan L; Colle R; Rotenberg S; Seif I; Robert P; David D; Guilloux JP; Gardier AM; Verstuyft C; Becquemont L; Corruble E; Guiard BP
Neuropharmacology; 2016 Jun; 105():142-153. PubMed ID: 26764241
[TBL] [Abstract][Full Text] [Related]
34. Vortioxetine: a New Treatment for Major Depressive Disorder.
Connolly KR; Thase ME
Expert Opin Pharmacother; 2016; 17(3):421-31. PubMed ID: 26679430
[TBL] [Abstract][Full Text] [Related]
35. Most antidepressant drugs are safe for patients with epilepsy at therapeutic doses: A review of the evidence.
Kanner AM
Epilepsy Behav; 2016 Aug; 61():282-286. PubMed ID: 27236241
[TBL] [Abstract][Full Text] [Related]
36. Hippocampal mossy cell involvement in behavioral and neurogenic responses to chronic antidepressant treatment.
Oh SJ; Cheng J; Jang JH; Arace J; Jeong M; Shin CH; Park J; Jin J; Greengard P; Oh YS
Mol Psychiatry; 2020 Jun; 25(6):1215-1228. PubMed ID: 30837688
[TBL] [Abstract][Full Text] [Related]
37. Differential modulation of Nav1.7 and Nav1.8 channels by antidepressant drugs.
Thériault O; Poulin H; Beaulieu JM; Chahine M
Eur J Pharmacol; 2015 Oct; 764():395-403. PubMed ID: 26187311
[TBL] [Abstract][Full Text] [Related]
38. Antidepressants for people with epilepsy and depression.
Maguire MJ; Marson AG; Nevitt SJ
Cochrane Database Syst Rev; 2021 Apr; 4(4):CD010682. PubMed ID: 33860531
[TBL] [Abstract][Full Text] [Related]
39. Sex-Based Impact of Creatine Supplementation on Depressive Symptoms, Brain Serotonin and SSRI Efficacy in an Animal Model of Treatment-Resistant Depression.
Kanekar S; Ettaro R; Hoffman MD; Ombach HJ; Brown J; Lynch C; Sheth CS; Renshaw PF
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360959
[TBL] [Abstract][Full Text] [Related]
40. Developmental exposure to SSRIs, in addition to maternal stress, has long-term sex-dependent effects on hippocampal plasticity.
Rayen I; Gemmel M; Pauley G; Steinbusch HW; Pawluski JL
Psychopharmacology (Berl); 2015 Apr; 232(7):1231-44. PubMed ID: 25304865
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
